Wells Fargo’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-450,121
| Closed | -$61.4M | – | 7403 |
|
|
2020
Q3 | $61.4M | Buy |
450,121
+27,276
| +6% | +$2.9M | 0.02% | 772 |
|
|
2020
Q2 | $40.9M | Buy |
422,845
+32,479
| +8% | +$2.71M | 0.01% | 946 |
|
|
2020
Q1 | $18.3M | Buy |
390,366
+98,924
| +34% | +$6.34M | 0.01% | 1275 |
|
|
2019
Q4 | $21.2M | Buy |
291,442
+2,684
| +0.9% | +$163K | 0.01% | 1420 |
|
|
2019
Q3 | $15.1M | Sell |
288,758
-5,856
| -2% | -$311K | ﹤0.01% | 1630 |
|
|
2019
Q2 | $14.8M | Buy |
294,614
+27,131
| +10% | +$1.32M | ﹤0.01% | 1662 |
|
|
2019
Q1 | $13.9M | Sell |
267,483
-4,008
| -1% | -$185K | ﹤0.01% | 1700 |
|
|
2018
Q4 | $13.3M | Sell |
271,491
-86,980
| -24% | -$4.79M | ﹤0.01% | 1670 |
|
|
2018
Q3 | $23.4M | Buy |
358,471
+81,838
| +30% | +$4.81M | 0.01% | 1410 |
|
|
2018
Q2 | $13.7M | Buy |
276,633
+30,115
| +12% | +$1.46M | ﹤0.01% | 1810 |
|
|
2018
Q1 | $12M | Sell |
246,518
-109,295
| -31% | -$5.68M | ﹤0.01% | 1848 |
|
|
2017
Q4 | $15M | Sell |
355,813
-61,626
| -15% | -$2.37M | ﹤0.01% | 1684 |
|
|
2017
Q3 | $17.9M | Buy |
417,439
+398,900
| +2,152% | +$12.7M | 0.01% | 1493 |
|
|
2017
Q2 | $243K | Buy |
18,539
+455
| +3% | +$6K | ﹤0.01% | 4663 |
|
|
2017
Q1 | $238K | Sell |
18,084
-21,839
| -55% | -$280K | ﹤0.01% | 4711 |
|
|
2016
Q4 | $517K | Buy |
39,923
+32,223
| +418% | +$496K | ﹤0.01% | 4181 |
|
|
2016
Q3 | $125K | Hold |
7,700
| – | – | ﹤0.01% | 4772 |
|
|
2016
Q2 | $96K | Buy |
7,700
+2,674
| +53% | +$33.4K | ﹤0.01% | 4862 |
|
|
2016
Q1 | $54K | Sell |
5,026
-5,265
| -51% | -$47.9K | ﹤0.01% | 5197 |
|
|
2015
Q4 | $150K | Buy |
+10,291
| New | +$126K | ﹤0.01% | 4641 |
|
Wells Fargo's MYOK Position: Q4 2020 in Review
Wells Fargo sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 450,121 shares — an estimated $61.4M sold.
Wells Fargo first reported a position in MYOK in Q4 2015 and held it in 20 quarters. The position peaked at $61.4M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Wells Fargo reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Wells Fargo sold 450,121 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $61.4M.
- Wells Fargo first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 20 quarters.
- Wells Fargo's MyoKardia, Inc. Common Stock position peaked at $61.4M in Q3 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Wells Fargo's 13F filing for Q4 2020, filed 9 Feb 2021.